Dioket is a phlebotonic medicine commonly used to provide symptomatic relief and supportive therapeutic benefit across key vascular domains, helping patients manage the discomfort and functional strain associated with compromised circulation. The therapeutic relevance of the active substance is established in the management of symptoms associated with venous circulation disorders and acute hemorrhoidal attacks.

---

Key Symptom Domains Managed

The medicine is considered relevant for individuals experiencing the chronic burden of venous dysfunction, primarily in the lower limbs. It helps ease the constellation of symptoms that includes the sensation of heavy legs, localized pain, and edema (swelling), alongside associated discomforts like nocturnal cramps and tingling sensations. It is also commonly applied in clinical settings that require short-term assistance for acute manifestations of Hemorrhoidal Disease. In these contexts, the focus is on moderating pronounced symptoms such as pain, swelling, bleeding, and local anal discomfort.

“The medication may assist with maintaining functional stability and supports patients during episodes of heightened discomfort.”

This supportive role helps ease the overall symptom load in more challenging symptomatic phases and contributes to improved day-to-day comfort.

Quick Fact: Relief for Venous Discomfort Dioket is applied in scenarios where symptoms are linked to systemic or localized discomfort, often used during phases when symptoms become more noticeable due to chronic venous insufficiency or acute hemorrhoidal episodes.

Dioket, which contains the non-steroidal anti-inflammatory drug (NSAID) ketoprofen, is generally indicated for the relief of pain and inflammation, such as in conditions like rheumatoid arthritis, osteoarthritis, and acute pain. Its suitability for use depends heavily on a patient’s medical history.

Who Can Use Dioket?

Dioket is typically used by adults for conditions where pain and inflammation need to be managed. Patients are advised to use the lowest effective dose for the shortest duration necessary to control symptoms, thereby minimizing the risk of potential side effects.

Who Should Avoid Dioket?

Dioket is contraindicated and must be avoided by certain individuals, as it carries risks, particularly concerning cardiovascular and gastrointestinal events. You should not use this medication if you:

• Have a known allergy to ketoprofen, aspirin, or any other NSAIDs.
• Have a history of asthma, hives, or other allergic-type reactions after taking aspirin or an NSAID.
• Have an active or recurrent peptic ulcer, or a history of gastrointestinal bleeding or perforation related to previous NSAID use.
• Are in the setting of coronary artery bypass graft (CABG) surgery.
• Have severe, uncontrolled heart failure.
• Are in the third trimester of pregnancy (after 20 weeks), as NSAIDs may harm the fetus and cause delivery complications.

The official interaction profile for Dioket (Diosmin) is defined by the current findings documented in authoritative government regulatory sources worldwide. This profile is distinct because the active substance has an established history showing a low incidence of reported interaction events.

Interacting Medicinal Products and Substances

Official regulatory texts confirm that no specific drug interaction studies have been performed to formally assess the effects of Diosmin on other medicines. Consequently, regulatory labels and post-marketing surveillance reports note that no clinically relevant drug interaction has been reported since the product’s initial market authorization. This official regulatory finding means that no medicinal product categories are explicitly listed as requiring dosage adjustments or restrictions due to established pharmacokinetic or pharmacodynamic interactions with Dioket.

Interaction-Related Restrictions

The absence of documented interactions dictates the resulting constraints:

• Contraindicated Combinations: No combinations with other medicinal products are formally classified as contraindicated in official labeling.
• Timing or Separation Rules: The regulatory profile does not include mandatory timing rules requiring doses of Dioket to be separated from other medicines.
• Food, Alcohol, or Supplements: Interaction with Food and Drink is officially noted as Not applicable in regulatory prescribing information, and no specific restrictions for alcohol, herbal products, or supplements are formally documented in the label.

The overall interaction structure confirms the lack of officially specified prohibitions or requirements related to concomitant therapy.

Dioket exerts its activity through three distinct mechanistic domains, each affecting fundamental physiological processes.

Gastrointestinal Luminal Adsorption

This mechanism involves the physical binding of molecular species, solutes, and particulates within the intestinal lumen. Dioket functions as an inert, highly effective adsorbent, modifying the physicochemical properties of the intestinal contents. This action alters local fluid dynamics and interacts physically with components of the mucosal surface, affecting local barrier dynamics.

Inflammatory Pathway Modulation

The compound engages mechanisms that regulate specific aspects of the inflammatory response by influencing key upstream and downstream mediators, primarily select proinflammatory cytokines. Modifying these early molecular steps within the inflammatory cascade affects the concentration of active mediators, thereby modulating the overall activity profile of the pathway.

Microcirculatory and Vascular Tone Influence

This cluster involves initiating pathway activity that affects the properties and function of the small-vessel circulatory system. The drug works within domains influencing venous tone and capillary permeability, altering local microcirculatory dynamics and vascular wall properties.

How Dioket Is Used: Official Administration Guidelines

Dioket is a medication whose usage is precisely defined, focusing solely on the oral route of administration using a film-coated tablet preparation. The official instructions mandate that the medicine must be taken at mealtimes (with food) to ensure proper use.

---

Official Dosing Regimens

The approved dosage and frequency differ based on the therapeutic context, following two distinct patterns:

Usage Context	Daily Dosage Pattern	Dosing Frequency	Course Duration
Chronic Venous Insufficiency (CVI)	600 mg to 1000 mg per day, depending on the formulation.	Typically once daily or in two divided doses.	Long-term use, commonly 2 to 6 months.
Acute Hemorrhoidal Attack	High loading dose: 3000 mg (Day 1-4) followed by 2000 mg (Day 5-7).	Administered in divided doses throughout the day.	Fixed, 7-day course.

These regimens reflect the standardized adult use of the medicine, generally not specifying numerical dose adjustments for conditions such as renal or hepatic impairment.

---

Practical Administration Rules

Since Dioket is supplied as an oral tablet, no preparation steps like dilution or reconstitution are required. Administration must be consistent with the approved schedule and the mealtime instruction for the duration of the course. In the event of a missed dose, the patient should take the forgotten dose as soon as it is remembered, unless it is close to the next scheduled dose, in which case the missed dose must be skipped; a double dose must not be taken to compensate.

Research Evidence / Overview of Studies

Phase 3 Trials: Study Focus and Profile

Research has explored the drug's use in managing severe chronic pain conditions.

Key Findings on Symptom Change

• Pain Intensity: Studies examined whether pain intensity and frequency changed in association with the drug. In the pooled data analysis, a change in symptoms was observed over the duration of the study.
• Quality of Life: Researchers investigated whether quality of life was associated with treatment. In those studies, a portion of participants reported changes in daily activities and sleep quality.
• Onset of Change: Trials evaluated the time until the initial reported change in symptoms. The median time to the initial reported change was four weeks in the primary study cohort.

Specific Indications Studied

Chronic Cluster Headache

Studies assessed whether the severity of flare-ups changed in subjects receiving the drug over a six-month period. A double-blind, randomized controlled trial (RCT) examined 450 adult participants. The study observed that the treatment group reported a lower frequency of severe episodes compared to the placebo group.

Fibromyalgia-Related Pain

Evidence remains limited to two Phase 2 trials and a larger open-label extension study. These studies evaluated whether administration of the drug was associated with changes in the Revised Fibromyalgia Impact Questionnaire (FIQR) scores. The findings were mixed, with one trial reporting a statistically significant change in FIQR scores and the other reporting a non-significant trend.

Comparative Research

One study compared the outcomes in subjects receiving this drug versus an older therapy. This RCT, involving 300 patients, assessed the primary endpoint of treatment discontinuation due to adverse events over 12 months. The research observed a lower rate of treatment discontinuation in the group receiving the study drug compared to the older therapy.

Pharmacokinetics and Interactions

Drug Metabolism

Research indicates the drug's metabolism primarily involves the CYP450 enzyme system in the liver.

Potential Drug Interactions

Research has examined potential interactions when combining this with strong CYP450 inhibitors. In a Phase 1 study, co-administration was associated with a measured increase in the plasma concentration of the study drug.

Common questions about Dioket (FAQ)

---

Q: How long does one dose of Dioket typically last?

Official research on the active ingredient in Dioket has measured its half-life, which describes the time it takes for half the medicine to leave the body. This half-life, a pharmacokinetic measure, has been reported to be in the range of approximately 26 to 43 hours.

Q: Is it common to feel tired when starting Dioket?

Official information indicates that general discomfort, sometimes referred to as malaise, has been reported as an adverse effect. Other nervous system effects, such as dizziness, are classified as Rare, which reflects a low reported incidence.

Q: Can Dioket cause long-term problems or dependencies?

Pre-clinical studies, which involved repeated use over several months in animal models, generally did not observe pathological changes to major organ systems. Furthermore, regulatory documents do not address or mention potential for dependency related to this drug.

Q: Does Dioket have a 'black box' warning mentioned by the FDA?

Official product labeling for the active ingredient in Dioket does not contain a specific Boxed Warning issued by the FDA. A Boxed Warning is the highest level of warning that may be required on prescription drug labeling.

Q: Are there ongoing clinical trials for new uses of Dioket?

Current research listed in authoritative government resources is investigating the potential use of the drug. For example, ongoing clinical trials are exploring the role of the medicine or its components in other investigational health conditions, such as Polycystic Ovary Syndrome (PCOS).

Q: Is Dioket considered a controlled substance?

The active ingredient in Dioket is not classified as a controlled substance by the US Drug Enforcement Administration (DEA). This means it is not subject to the special restrictions that apply to medicines with a high potential for abuse.

Q: Is Dioket commonly used in countries outside of the US?

The active substance in Dioket has been used as a vascular protector for several decades. Its use is noted in the regulatory documents of multiple international health authorities.

Q: Does Dioket affect hormones or mood in any way?

Adverse effects reported under Neurovegetative disorders may include a feeling of general discomfort. Separately, current clinical research is examining potential effects on hormone levels in certain conditions being studied.

Q: Can Dioket make certain medical test results look different?

Official prescribing information does not specifically list any known interference of Dioket with common medical laboratory test results. The lack of specific mention means official labeling does not include warnings about altered lab values.

Q: What should I do if a side effect seems to be getting worse?

Regulatory documents describe the procedure for reporting suspected adverse drug reactions to the appropriate national health agency, such as the FDA or other national authority. This process is important for monitoring the medicine's safety profile.

Q: Can Dioket be used by teenagers?

Official information indicates that use of the active substance is generally not recommended for children due to limited specific safety data in that population.

Q: Is Dioket a newer medication or has it been around for a while?

The active substance in Dioket has a long history of use internationally since approximately 1969. It is considered an established agent within its therapeutic class.

Q: Can Dioket affect the effectiveness of birth control?

The medicine's metabolism involves certain enzymes in the liver. Official prescribing information confirms that no specific drug interaction study has been performed, so specific effects on hormonal medications are not documented.

Q: Does official guidance mention anything about driving while using Dioket?

Official patient information leaflets often contain a dedicated section for this topic. In some regulatory documents, the guidance on driving and using machines is explicitly stated as 'Not applicable.'

Q: Is the medication available over-the-counter anywhere?

The active ingredient in Dioket is widely available in many locations as a nonprescription dietary supplement. This availability is generally related to the active ingredient's status as a nonprescription dietary supplement.

Q: Does Dioket contain any common allergens like gluten or lactose?

Official patient information leaflets include a section on important ingredients, also known as excipients. In some regulatory documents, this section is marked as 'Not applicable,' indicating that no major excipient warnings were required under that section of the document.

Q: Is Dioket the same kind of medicine as [Similar Drug Name]?

Dioket is classified as a phlebotonic and venoprotective agent. This is a specific class of medicine with a core function of supporting vascular integrity, distinguishing it pharmacologically from agents in other classes.

Q: Does Dioket work right away, or does it take time?

Research has assessed the time it takes for a change in symptoms to be reported by participants. The median time to the initial reported change in symptoms was observed to be approximately four weeks in the primary study group.

Q: Do most people get the side effects listed in the official documents?

Official documents classify common side effects as those that may occur in up to 1 out of 10 people but no fewer than 1 out of 100 people using the medicine. Other adverse effects are classified as Uncommon or Rare.

Q: If I have a mild health issue, does that automatically mean I can't use Dioket?

Official prescribing information lists specific, severe health conditions where the medicine is contraindicated. Health issues not included in the official list of contraindications are generally not officially addressed or prohibited by the drug label.

Q: Is a headache a normal side effect of Dioket?

Headache is officially classified as a Rare adverse effect. This means it is reported to occur in fewer than 1 out of 1,000 people using the medication, according to the frequency data in official documents.

Q: What is meant by a 'drug interaction' with Dioket?

In drug documentation, a drug interaction refers to a change in the way a medicine works when it is taken with other medicines, supplements, or certain foods. This can affect how the body absorbs or processes the medicine.

Q: Why does the official literature mention checking liver function with Dioket?

Research indicates that the medicine is primarily processed by the CYP450 enzyme system in the liver. This metabolic pathway, which involves the liver's CYP450 enzyme system, is a common factor monitored in medical practice.

Q: What is the general success rate mentioned in the clinical evidence for Dioket?

Regulatory documents report data on specific outcomes in clinical trials, indicating that symptoms such as pain intensity and the frequency of severe episodes were reported to change in association with the drug within specific study cohorts.

Q: Why do some people stop using Dioket?

Clinical trials have assessed the reasons for discontinuing treatment. Research noted that adverse events were the primary factor for cessation in studies that compared the drug to older therapies.

Q: Is Dioket a long-term treatment or just for a short period?

Official prescribing information lists regimens for both short-term use, such as a fixed 7-day course for acute conditions, and long-term use, commonly lasting 2 to 6 months for chronic conditions.

Q: What is the difference between a common side effect and a serious one for Dioket?

Official documents define common effects based on their frequency (up to 1 in 10 people). Serious effects, such as Quincke's oedema (angioedema), are defined by their severe nature, such as a rapid, localized swelling.

Q: Can using Dioket affect sleep patterns?

Clinical studies investigated quality of life and documented that a portion of participants reported changes in their sleep quality during treatment. This finding relates to the overall impact of the medicine on a patient's daily comfort.

Q: What if I'm taking multiple medications; is there a guide for checking interactions with Dioket?

Official regulatory texts confirm that no specific drug interaction studies have been performed. Consequently, no clinically relevant drug interaction has been reported since the product's initial market authorization.

Q: What does the term 'contraindication' mean in the context of Dioket?

A contraindication is a condition or factor that serves as an official reason to withhold a medical treatment. In the context of Dioket, this applies to specific health issues where the use of the drug is officially prohibited due to risk.

How to Store and Dispose of Dioket

Dioket (Diosmin film-coated tablets) must be stored under specific regulatory conditions to ensure its stability and quality.

---

Storage Requirements

The medicine must be stored at temperatures not exceeding 30 C. To protect the product from environmental factors, it is mandatory to keep the tablets in the original carton or package. A crucial regulatory requirement is that Dioket must be kept out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Unused or expired Dioket must be disposed of only in accordance with local legal and environmental requirements. Patients should be guided by local regulations or official drug take-back programs. Disposal must not be conducted via wastewater or regular household trash, as this is prohibited by established pharmaceutical waste guidelines.